BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Valley Forge Scientific (VLFG) To Announce Fourth Quarter And FY 2004 Revenue And Earnings -- Wednesday, December 22, 2004


10/19/2005 5:12:28 PM

OAKS, Pa., Dec. 14 /PRNewswire-FirstCall/ -- Valley Forge Scientific announced today that it will host a conference call on Wednesday, December 22, 2004 at 10:30 a.m., EST to discuss revenue and earnings for the fiscal fourth quarter and year ending September 30, 2004.

The toll free dial-in number to listen and participate live on this call is (877) 356-9134, confirmation code 2818955. For callers outside the U.S., the number is (706) 643-3775. An audiotape replay will be available approximately two hours following the conclusion of the call through Tuesday, January 4, 2005 and can be accessed by dialing toll free (800) 642-1687, confirmation code 2818955. Callers outside the U.S. can access this recording at (706) 645-9291.

Valley Forge Scientific, a developer and manufacturer of medical device products for hospital and healthcare markets worldwide, has established itself as a leading developer and manufacturer of bipolar electrosurgical systems and related instrumentation. Based on its patented DualWave(TM) technology, these systems provide surgeons with the ability to safely cut and coagulate tissue in the most critical areas of the brain and spinal cord.

THE "SAFE HARBOR" STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995.

Statements in this press release regarding our expectations for our products or products we are developing, introduction of products into the marketplace, acceptance of our products in the marketplace, new products and alliances, and any other statements in this press release that refer to Valley Forge Scientific's estimated or anticipated future results are forward-looking statements within the meaning of the Private Securities Litigation Act of 1995. All forward-looking statements in this press release reflect Valley Forge Scientific's current analysis of existing trends and information and represent Valley Forge Scientific's judgment only as of the date of this press release. Actual results may differ from current expectations based on a number of factors affecting Valley Forge Scientific's business, including but not limited to competitive, regulatory and market conditions; the performance of new products and the continued acceptance of current products; the execution of strategic initiatives and alliances; the market penetration by third parties who distribute and sell Valley Forge Scientific's products; Valley Forge Scientific's ability to maintain a sufficient supply of products; product liability claims; and the uncertainties associated with intellectual property protection for these products. In addition, matters generally affecting the domestic and global economy can affect Valley Forge Scientific's results. Therefore, the reader is cautioned not to rely on these forward- looking statements. Valley Forge Scientific disclaims any intent or obligation to update these forward-looking statements.

Additional information concerning these and other risk factors may be found in Valley Forge Scientific's public periodic filings with the Securities and Exchange Commission, including Valley Forge Scientific's Form 10-K for the year ended September 30, 2003.

COMPANY CONTACT: Jerry Malis CEO and President 136 Green Tree Rd., Ste. 100 P.O. Box 1179 Oaks, PA 19456 E:MAIL: ir@vlfg.com PHONE: (610) 666-7500 FAX: (610) 666-7565

Valley Forge Scientific

CONTACT: Jerry Malis, CEO and President, Valley Forge Scientific,ir@vlfg.com, Phone: +1-610-666-7500, Fax: +1-610-666-7565



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES